AFR
Phan also likes ASX-listed regenerative medicine business Avita Medical, which uses a spray formed from patients’ own cells to repair burns victims’ skin, or to treat common disorders such as vitiligo.“After nearly 20 years of development, Avita’s Recell ‘spray-on-skin’ is fast on its way to becoming a component of standard of care in the US,” Phan says. “Under the new CEO, it’s growing revenue strongly, targeted to reach $US100 million within two years, selling into a multibillion-dollar market.”
Why AVH is a bargain right now / chart, page-125
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.42 |
Change
0.010(0.41%) |
Mkt cap ! $160.4M | |||
| Open | High | Low | Value | Volume |
| $2.42 | $2.45 | $2.41 | $562.3K | 231.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 82002 | $2.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.43 | 16 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AVH (ASX) Chart |